27 January 2014
Luxembourg (27 January 2014) – ConvaTec, a privately-held developer and marketer of innovative medical technologies, today announced that John Cannon has been named Chief Financial Officer of the company.
Mr. Cannon had been serving as ConvaTec’s acting CFO since last July.
“John has done a truly outstanding job, and I am pleased to name him officially to the CFO role,” said Ken Berger, CEO of ConvaTec.
ConvaTec is a global medical products and technologies company, with leading market positions in ostomy care, wound therapeutics, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in eight countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners.